Klinische Studie

A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds

NCT: NCT07856797 · NOT_YET_RECRUITING

NCT-IDNCT07856797

Medizinische Daten: StatusNOT_YET_RECRUITING

SponsorMerz North America, Inc. (INDUSTRY)

First posted2026-10-05

Last updated2026-10-05

Kurzzusammenfassung

The purpose of this study is to confirm the long-term safety, effectiveness, and degradation profile of RADIESSE® Injectable Implant for the correction of moderate to severe nasolabial folds (NLFs) in Chinese adults. Eligible participants will receive treatment with RADIESSE® Injectable Implant in both NLFs and may receive an optional touch-up treatment at Month 1 at investigator's discretion. Participants will be followed for up to 24 months after last treatment.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.